Abstract:Prostate cancer is one of the most prevalent cancers diagnosed in adult males. Described as an omnipresent illness, it is believed that the diagnosis is inevitable for men as life expectancy increases worldwide. Clinically, a diagnosis of prostate cancer is determined by measuring quantitatively prostate-specific antigen (PSA) protein in blood serum. It has been implicated that high PSA concentrations in blood plasma is a biomarker for not only prostate cancer but also the metastasis of the tumor cells into the bone and lymph nodes via IGFBP-3/IGF-I & -II and TGF-β pathways. Although the precise role of PSA in carcinogensis and tumor progression is currently disputed, compounds specific towards PSA binding have been synthesized towards understanding the molecular mechanisms of the protease and inhibiting its proteolytic activity. Here, we describe the mechanism of α-aminoalkylphosphonate ester derivatives as potent irreversible inhibitors of PSA. Autodock4.2 molecular dynamics package was utilized to model covalent and non-covalent binding of this class of inhibitors to predict crystallographic poses and compare experimental IC50 dose-response curves and in silico potencies for future rational drug design research. The study not only introduces aminoalkylphosphonates as a potential drug candidate for targeting PSA, but also provides insight to drug binding and validation of Autodock4.2 in future drug development using quantitative structure-activity relationships.

Improved Synthesis of 17-(5′-isoxazolyl)androst-4,16-dien-3-one,a Potential Agent for the Treatment of Prostate Cancer

Synthesis technology of 3-n-propyl-2, 4-dihydroxyacetophenone

An Efficient Synthesis of 5Α-Androst-1-ene-3,17-dione

Syntheses of Some 17-Heterocyclic Substituted Androstene Derivatives as Inhibitors of Human 17α-Hydroxylase/C17,20-layse(P45017α)

Practical synthesis of androgen: the efficient transformation of 17-oxo group to 17α-hydroxy group

Syntheses and Pharmacological Activity of Some 17-[(2＇-Substituted)4＇-pyrimidyl]androstene Derivatives As Inhibitors of Human 17αHydroxylase/C17,20-Layse

Design and Synthesis of Novel Dehydroepiandrosterone Analogues As Potent Antiproliferative Agents

Synthesis and Modeling of Novel Α-Aminoalkylphosphonate Ester Derivatives As Potent Inhibitors of Prostate-Specific Antigen; A Comparison Study

Improved Synthetic Method of Anticancer Drug Anastrozole

Synthesis of (17R)- and (17S)-17-hydroxy-14, 15-secoandrost-4-en-15-yn-3-one and the X-ray crystal structure of the (17S)-diastereomer

Discovery of novel 1,2,3,4-tetrahydrobenzo[4, 5]thieno[2, 3-c]pyridine derivatives as potent and selective CYP17 inhibitors.

Synthesis of N-Substituted 3-Oxo-17b- Carboxamide-4-aza-5a-androstanes and the Tautomerism of 3-Oxo-4-aza-5-androstenes

SYNTHESIS OF (17R) AND (17S)-17-HYDROXY-14,15-SECOANDROST-4-EN-16-YN-3-ONE AND THE X-RAY CRYSTAL-STRUCTURE OF THE (17S)-DIASTEREOMER

Studies on Synthesis of Finasteride

Synthesis and Biological Evaluation of Methoxypolyethylene-Glycol-Substituted Abiraterone Derivatives as Potential Antiprostate Cancer Agents

Design, synthesis and biological evaluation of novel thiosemicarbazone-indole derivatives targeting prostate cancer cells

Design, synthesis and biological evaluation of novel thiohydantoin derivatives as potent androgen receptor antagonists for the treatment of prostate cancer

Pictet-Spengler condensations using 4-(2-aminoethyl)coumarins

Synthesis, Optimization, In Silico, and In Vitro Testing of D-Homo Lactone Estra-1,3,5-triene Derivatives

Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors

Synthesis of new derivatives of 21-imidazolyl-16-dehydropregnenolone as inhibitors of 5α-reductase 2 and with cytotoxic activity in cancer cells